British Journal of Urology · 1990 · 10 citations · 10 references
MedicinePharmacologyPharmacotherapyChemotherapyClinical PharmacologyDrug DeliveryScleral DisordersScleral SurgerySclerosing Therapy
We present a prospective single-blind trial of sclerotherapy for hydroceles with tetradecyl sulphate and rolitetracycline as sclerosants. Twenty-seven hydroceles were treated with tetradecyl sulphate and 28 with rolitetracycline. The median follow-up was 13 months. There were no statistically significant differences between the 2 drugs in respect of cure rate and complications. The overall cure rate for both drugs was 96%. Complications were rare and common to both drugs. Tetradecyl sulphate and rolitetracycline were found to be equally effective as sclerosants.
10
Sclerotherapy with tetracycline solution for hydrocele
Kang‐Ning Hu, Ali Khan, Maurice J. Gonder · Urology · 1984 · 41 citations
Sclerotherapy for hydrocele and epididymal cysts: a five year study.
J R Nash · BMJ · 1984 · 36 citations · Full text
Medicine, Surgery, Microsurgery +3
Reversal with balsalazide of infertility caused by sulphsalazine.
Peter McIntyre, J E Lennard‐Jones · BMJ · 1984 · 36 citations · Full text